Motus GI (MOTS) Competitors $0.0001 0.00 (-50.00%) (As of 12/20/2024 03:04 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends MOTS vs. BRSH, DRTSW, ANZUW, BBLGW, BRSHW, GMVDW, HSCSW, BEATW, LUCYW, and IINNWShould you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), and Inspira Technologies Oxy B.H.N. (IINNW). These companies are all part of the "medical equipment" industry. Motus GI vs. Bruush Oral Care Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. Motus GI (NASDAQ:MOTS) and Bruush Oral Care (NASDAQ:BRSH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, community ranking, profitability, institutional ownership, analyst recommendations, earnings and valuation. Does the media refer more to MOTS or BRSH? In the previous week, Motus GI's average media sentiment score of 0.00 equaled Bruush Oral Care'saverage media sentiment score. Company Overall Sentiment Motus GI Neutral Bruush Oral Care Neutral Do institutionals and insiders believe in MOTS or BRSH? 20.1% of Motus GI shares are owned by institutional investors. Comparatively, 31.9% of Bruush Oral Care shares are owned by institutional investors. 0.3% of Motus GI shares are owned by insiders. Comparatively, 29.8% of Bruush Oral Care shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has stronger earnings & valuation, MOTS or BRSH? Bruush Oral Care has higher revenue and earnings than Motus GI. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMotus GI$319K0.00-$12.87M-$15.640.00Bruush Oral Care$2.92M0.00N/AN/AN/A Which has more risk and volatility, MOTS or BRSH? Motus GI has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Comparatively, Bruush Oral Care has a beta of 2.76, indicating that its stock price is 176% more volatile than the S&P 500. Does the MarketBeat Community believe in MOTS or BRSH? Motus GI received 163 more outperform votes than Bruush Oral Care when rated by MarketBeat users. CompanyUnderperformOutperformMotus GIOutperform Votes16365.73% Underperform Votes8534.27% Bruush Oral CareN/AN/A Is MOTS or BRSH more profitable? Bruush Oral Care has a net margin of 0.00% compared to Motus GI's net margin of -3,239.75%. Bruush Oral Care's return on equity of 0.00% beat Motus GI's return on equity.Company Net Margins Return on Equity Return on Assets Motus GI-3,239.75% -1,731.08% -115.99% Bruush Oral Care N/A N/A N/A SummaryBruush Oral Care beats Motus GI on 7 of the 9 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get Motus GI News Delivered to You Automatically Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MOTS vs. The Competition Export to ExcelMetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1,000.00$4.33B$5.12B$9.07BDividend YieldN/A41.46%4.91%4.22%P/E Ratio0.0025.3791.3417.19Price / Sales0.0045.671,116.63116.80Price / CashN/A43.4642.5837.86Price / Book0.007.364.794.78Net Income-$12.87M$13.64M$120.07M$225.60M7 Day PerformanceN/A-2.81%-1.90%-1.24%1 Month PerformanceN/A0.55%11.43%3.06%1 Year PerformanceN/A41.80%30.59%16.50% Motus GI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MOTSMotus GIN/A$0.00-50.0%N/A-100.0%$1,000.00$319,000.000.0030Gap DownHigh Trading VolumeBRSHBruush Oral CareN/A$0.00flatN/A-99.4%$1,000.00$2.92M0.0011Gap DownDRTSWAlpha Tau MedicalN/A$0.20-18.5%N/A+72.0%$0.00N/A0.0080Positive NewsGap DownANZUWAnzu Special Acquisition Corp IN/A$0.09-1.1%N/A+92.3%$0.00N/A0.002BBLGWBone BiologicsN/A$27.80flatN/A+1,034.7%$0.00N/A0.002BRSHWBruush Oral CareN/A$0.01-1.8%N/AN/A$0.00$2.92M0.0011Gap UpGMVDWG Medical InnovationsN/A$6.90+26.4%N/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.04+32.9%N/A-99.2%$0.00$18,600.000.0010BEATWHeartBeamN/A$0.84-11.6%N/AN/A$0.00N/A0.005Positive NewsLUCYWInnovative EyewearN/A$0.05+2.3%N/A-49.2%$0.00$1.56M0.009Gap DownIINNWInspira Technologies Oxy B.H.N.N/A$0.21-14.3%N/A+92.3%$0.00N/A0.0020Positive NewsGap Down Related Companies and Tools Related Companies BRSH Alternatives DRTSW Alternatives ANZUW Alternatives BBLGW Alternatives BRSHW Alternatives GMVDW Alternatives HSCSW Alternatives BEATW Alternatives LUCYW Alternatives IINNW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MOTS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motus GI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Motus GI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.